Kristin Joly
About Kristin Joly
Kristin Joly serves as the Director of In Vivo Operations at Inotiv, a position she has held since 2021. She has extensive experience in the biopharmaceutical industry, having previously worked at Gilead Sciences and Plato BioPharma, Inc.
Work at Inotiv
Kristin Joly serves as the Director of In Vivo Operations at Inotiv, a position she has held since 2021. In this role, she is responsible for overseeing various aspects of in vivo research operations. Her leadership contributes to the company's commitment to advancing preclinical research and development. Inotiv is located in Westminster, Colorado, where Joly applies her extensive experience in the biopharmaceutical sector.
Previous Experience at Gilead Sciences
Before joining Inotiv, Kristin Joly worked at Gilead Sciences as a Senior Research Associate I from 2005 to 2009. During her four years at Gilead, she contributed to research initiatives that supported the development of therapeutic solutions. This role provided her with foundational experience in the biopharmaceutical industry.
Career at Plato BioPharma, Inc.
Kristin Joly held multiple positions at Plato BioPharma, Inc. from 2010 to 2021. She started as a Senior Research Associate II, where she worked for six years, before advancing to Associate Director of In Vivo Operations for five years. Her tenure at Plato BioPharma allowed her to develop expertise in in vivo operations and management, preparing her for her current role at Inotiv.
Education and Expertise
Kristin Joly earned her Master of Science in Forensic Science from the University of New Haven, studying from 2003 to 2005. Prior to that, she completed her Bachelor of Science in Biology at the University of Scranton from 1997 to 2001. Her educational background provides a strong foundation for her work in research and operations within the biopharmaceutical field.